Meta Biomed Co., Ltd. (KOSDAQ:059210)

Meta Biomed Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	14,517	10,796	13,226	10,113	8,639
Short-Term Investments	13,000	2,970	4,410	1,957	306.9
Trading Asset Securities	26,781	3,044	1,505	3,846	12,099
Cash & Short-Term Investments	54,298	16,810	19,141	15,916	21,044
Cash Growth	223.01%	-12.18%	20.26%	-24.37%	159.90%
Accounts Receivable	13,381	12,880	12,822	12,409	11,556
Other Receivables	1,379	1,652	1,682	636.92	572.76
Receivables	17,261	14,532	14,504	13,046	12,129
Inventory	18,775	15,402	14,734	15,276	16,963
Prepaid Expenses	1,678	1,954	1,158	100.45	313.4
Other Current Assets	1,945	1,227	1,439	1,322	1,673
Total Current Assets	93,957	49,924	50,976	45,661	52,123
Property, Plant & Equipment	64,099	59,086	52,123	39,278	42,726
Long-Term Investments	6,232	7,118	7,687	7,365	6,007
Goodwill	1,008	1,008	2,023	524.06	524.06
Other Intangible Assets	824.26	675.57	688.41	783.26	760.72
Long-Term Deferred Tax Assets	6,151	7,080	4,783	4,966	2,639
Long-Term Deferred Charges	-	-	-	70.9	1,185
Other Long-Term Assets	3,966	1,804	879.89	3,627	1,109
Total Assets	177,295	130,124	121,072	103,128	107,856
Accounts Payable	2,673	2,923	2,425	1,922	2,561
Accrued Expenses	1,403	1,303	910.41	1,121	890.21
Short-Term Debt	49,353	30,971	31,230	24,830	38,718
Current Portion of Long-Term Debt	299.33	728.19	948.68	5,532	1,041
Current Portion of Leases	435.83	246.82	145.81	187.8	312.17
Current Income Taxes Payable	261.83	6.75	10.1	42.1	86.56
Other Current Liabilities	19,171	8,293	9,147	4,527	3,801
Total Current Liabilities	73,597	44,471	44,817	38,161	47,410
Long-Term Debt	5,600	12,207	11,618	3,842	9,638
Long-Term Leases	434.4	294.66	128.76	87.6	199.2
Long-Term Deferred Tax Liabilities	-	-	-	192.08	282.67
Other Long-Term Liabilities	1,553	489.03	1,069	551.35	542.24
Total Liabilities	81,185	57,462	57,633	43,030	58,331
Common Stock	11,931	11,931	11,931	11,931	11,931
Additional Paid-In Capital	34,666	34,666	34,455	34,455	34,455
Retained Earnings	47,127	25,359	15,810	13,640	4,473
Treasury Stock	-2,982	-2,842	-2,842	-2,778	-2,778
Comprehensive Income & Other	2,597	933.39	1,237	1,075	-102.91
Total Common Equity	93,339	70,048	60,591	58,323	47,978
Minority Interest	2,771	2,614	2,848	1,775	1,547
Shareholders' Equity	96,110	72,662	63,439	60,099	49,525
Total Liabilities & Equity	177,295	130,124	121,072	103,128	107,856
Total Debt	56,123	44,448	44,072	34,478	49,909
Net Cash (Debt)	-1,824	-27,638	-24,931	-18,562	-28,864
Net Cash Per Share	-67.29	-1208.43	-1089.37	-810.54	-1252.73
Filing Date Shares Outstanding	22.83	22.87	22.87	22.9	22.9
Total Common Shares Outstanding	22.83	22.87	22.87	22.9	22.9
Working Capital	20,360	5,452	6,158	7,499	4,712
Book Value Per Share	4088.23	3062.71	2649.24	2546.74	2095.01
Tangible Book Value	91,506	68,364	57,879	57,016	46,693
Tangible Book Value Per Share	4007.95	2989.08	2530.67	2489.66	2038.91
Land	8,893	6,124	6,768	6,727	8,281
Buildings	35,704	34,817	21,322	20,924	22,274
Machinery	48,842	47,587	38,737	34,361	36,149
Construction In Progress	1,465	1,178	11,993	297.15	463.28

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.